In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Morepen Laboratories has informed that the Board of Directors at their meeting held today, Monday, 9th May, 2022 (commenced at 10:30 AM and concluded at 11:30 AM), approved the allotment of 1,14,65,201, 0.01%, Compulsorily Convertible Preference Shares ('CCPS') of Rs 100 each, convertible into 2,13,42,505 Equity Shares of Rs 2 each, at an issue price of Rs 53.72 per Equity Share, within a maximum period of 18 months in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended.
The above information is a part of company’s filings submitted to BSE.
